RE: Praluent (Alirocumab)-Induced Renal Injury

Members of the Phase 3 Data Monitoring Committee for PRALUENT

doi:10.1177/0897190017734429

RE: Praluent (Alirocumab)-Induced Renal Injury

Members of the Phase 3 Data Monitoring Committee for PRALUENT

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	138-139
Number of pages	2
Journal	Journal of Pharmacy Practice
Volume	31
Issue number	2
DOIs	https://doi.org/10.1177/0897190017734429
State	Published - 1 Apr 2018

Keywords

acute renal injury
alirocumab
rosuvastatin

Access to Document

10.1177/0897190017734429

Cite this

@article{1d5d8ee60f194034bbfa22b3151cf31a,

title = "RE: Praluent (Alirocumab)-Induced Renal Injury",

keywords = "acute renal injury, alirocumab, rosuvastatin",

author = "{Members of the Phase 3 Data Monitoring Committee for PRALUENT} and Rosenson, {Robert S.} and Dominique Larrey and Waters, {David D.} and Olsson, {Anders G.}",

year = "2018",

month = apr,

day = "1",

doi = "10.1177/0897190017734429",

language = "English",

volume = "31",

pages = "138--139",

journal = "Journal of Pharmacy Practice",

issn = "0897-1900",

publisher = "SAGE Publications Inc.",

number = "2",

}

TY - JOUR

T1 - RE

T2 - Praluent (Alirocumab)-Induced Renal Injury

AU - Members of the Phase 3 Data Monitoring Committee for PRALUENT

AU - Rosenson, Robert S.

AU - Larrey, Dominique

AU - Waters, David D.

AU - Olsson, Anders G.

PY - 2018/4/1

Y1 - 2018/4/1

KW - acute renal injury

KW - alirocumab

KW - rosuvastatin

UR - http://www.scopus.com/inward/record.url?scp=85043371282&partnerID=8YFLogxK

U2 - 10.1177/0897190017734429

DO - 10.1177/0897190017734429

M3 - Letter

C2 - 28974137

AN - SCOPUS:85043371282

SN - 0897-1900

VL - 31

SP - 138

EP - 139

JO - Journal of Pharmacy Practice

JF - Journal of Pharmacy Practice

IS - 2

ER -